818 related articles for article (PubMed ID: 19463576)
41. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
[TBL] [Abstract][Full Text] [Related]
42. Surgical treatment of superior sulcus tumors: results and prognostic factors.
Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
[TBL] [Abstract][Full Text] [Related]
43. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
44. Non-small cell lung cancer. The role of chemoimmunoradiotherapy after surgery.
Kshivets O
J Exp Clin Cancer Res; 2001 Dec; 20(4):491-503. PubMed ID: 11876542
[TBL] [Abstract][Full Text] [Related]
45. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
[TBL] [Abstract][Full Text] [Related]
46. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
47. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.
Lee PC; Korst RJ; Port JL; Kerem Y; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1382-9. PubMed ID: 17140961
[TBL] [Abstract][Full Text] [Related]
48. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
49. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
50. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
Uy KL; Darling G; Xu W; Yi QL; De Perrot M; Pierre AF; Waddell TK; Johnston MR; Bezjak A; Shepherd FA; Keshavjee S
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
[TBL] [Abstract][Full Text] [Related]
51. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary resection of non-small cell lung cancer: is survival in the elderly not affected by tumor stage after complete resection?
Bölükbas S; Beqiri S; Bergmann T; Trainer S; Fisseler-Eckhoff A; Schirren J
Thorac Cardiovasc Surg; 2008 Dec; 56(8):476-81. PubMed ID: 19012213
[TBL] [Abstract][Full Text] [Related]
53. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
54. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
56. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
Cerón J; Peñalver JC; Jordá C; Padilla J
Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
[TBL] [Abstract][Full Text] [Related]
57. Survival after surgery following chemotherapy for non-small-cell lung cancer.
Molnár TF; Balikó Z; Sárosi V; Horváth PO
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(2):141-6. PubMed ID: 20304848
[TBL] [Abstract][Full Text] [Related]
58. Characteristics and prognosis of resected T3 non-small cell lung cancer.
Ilhan M; Demir A; Akin H; Zek Gunluoglu M; Olçmen A; Dncer SI
Minerva Chir; 2008 Apr; 63(2):101-8. PubMed ID: 18427442
[TBL] [Abstract][Full Text] [Related]
59. Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC.
Steger V; Veit S; Walker T; Friedel G; Lehrach K; Mustafi M; Walles T
Thorac Cardiovasc Surg; 2013 Mar; 61(2):109-15. PubMed ID: 22821672
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]